Volume 15, Number 10—October 2009
CME ACTIVITY - Research
Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA
Table 2
Characteristic† | Total no. (%), N = 343 | USA type |
p value | |
---|---|---|---|---|
No. (%) USA300/400, n = 54 | No. (%) other,‡ n = 289 | |||
Mean age, y | 66.3 (SD = 17.0) | 50.6 (SD = 21.2) | 69.2 (SD = 14.4) | <0.0001 |
Female gender | 135 (39.4) | 14 (25.9) | 121 (41.9) | 0.059 |
Inpatient stay | 278 (81.0) | 50 (92.6) | 228 (78.9) | 0.271 |
ICU admission | 56 (16.3) | 8 (14.8) | 48 (16.7) | 0.348 |
Nosocomial infection |
57 (16.6) |
1 (1.9) |
56 (19.4) |
0.0006 |
Specimen type | 0.0021 | |||
Blood | 322 (93.9) | 45 (83.3) | 276 (95.0) | |
CSF | 0 | 0 | 0 | |
Joint fluid | 13 (3.8) | 5 (9.3) | 8 (2.9) | |
Pleural fluid | 2 (0.6) | 2 (3.7) | 0 | |
Other |
6 (1.7) |
2 (3.7) |
5 (1.4) |
|
Iowa region | 0.268 | |||
1 | 10 (2.9) | 0 | 10 (3.5) | |
2 | 93 (27.0) | 13 (24.1) | 80 (27.7) | |
3 | 49 (14.2) | 12 (22.2) | 37 (12.8) | |
4 | 105 (30. 5) | 16 (29.6) | 88 (30.5) | |
6 |
20 (5.8) |
5 (9.3) |
15 (5.2) |
|
PVL |
54 (15.7) |
52 (96.3) |
2 (0.7)§ |
<0.0001 |
SCCmec IV | 68 (19.8) | 54 (100.0) | 13 (4.5) | <0.0001 |
*MRSA, methicillin-resistant Staphylococcus aureus; ICU, intensive care unit; CSF, cerebrospinal fluid; PVL, Panton-Valentine leukocidin; SCCmec IV, Staphylococcal chromosomal cassette mec type IV.
†The number of patients missing data on specific variables: age = 10; gender = 12; inpatient = 31; ICU = 122; nosocomial = 101; specimen type = 0; Iowa Department of Public Health Reporting Region = 6; PVL = 3; SCCmec IV = 3.
‡Of the subset of isolates that were typed (N = 272) 94% were USA100. The remainder clustered with USA200 (5), USA500 (5), USA600 (1), USA800 (4), or did not match an existing USA type.
§Both isolates clustered with USA100 and were SCCmecII.
Page created: September 24, 2012
Page updated: September 24, 2012
Page reviewed: September 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.